Eco R1 Capital, LLC Unity Biotechnology, Inc. Transaction History

Eco R1 Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.42 - $6.36 $1.01 Million - $1.88 Million	-296,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $870,240 - $3.68 Million	296,000 New	296,000 $1.02 Million
Q4 2019 Feb 14, 2020	SELL	$5.99 - $8.38 $307,886 - $430,732	-51,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.62 - $9.63 $5.58 Million - $9.56 Million	-993,100 Reduced 95.08%	51,400 $314,000
Q2 2019 Aug 14, 2019	BUY	$7.59 - $10.21 $1.05 Million - $1.41 Million	137,886 Added 15.21%	1,044,500 $9.92 Million
Q1 2019 May 15, 2019	SELL	$7.65 - $16.66 $462,825 - $1.01 Million	-60,500 Reduced 6.26%	906,614 $7.35 Million
Q3 2018 Nov 14, 2018	SELL	$14.34 - $22.97 $10.2 Million - $16.4 Million	-713,530 Reduced 42.46%	967,114 $15.8 Million
Q2 2018 Aug 14, 2018	BUY	$12.76 - $16.94 $21.4 Million - $28.5 Million	1,680,644 New	1,680,644 $25.3 Million

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $31.2M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.